Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Nicholas DeMartinis |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder / Karl Rickels en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 1 (Febrero)
[artículo]
Título : A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder Tipo de documento: texto impreso Autores: Karl Rickels, Autor ; Nicholas DeMartinis, Autor ; Bernd Aufdembrinke, Autor Fecha de publicación: 2023 Artículo en la página: pp. 12-18 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Trastornos de ansiedad, Diazepam. Resumen: In a multicenter, double-blind trial, 310 patients who had received a diagnosis of generalized anxiety disorder were treated for 6 weeks with either abecarnil, diazepam, or placebo at mean daily doses of 12 mg of abecarnil or 22 mg of diazepam administered three times daily. Patients who were improved at 6 weeks could volunteer to continue double-blind treatment for a total of 24 weeks. Link: ./index.php?lvl=notice_display&id=31226
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 1 (Febrero) . - pp. 12-18[artículo] A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder [texto impreso] / Karl Rickels, Autor ; Nicholas DeMartinis, Autor ; Bernd Aufdembrinke, Autor . - 2023 . - pp. 12-18.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 1 (Febrero) . - pp. 12-18
Palabras clave: Ansiolíticos, Trastornos de ansiedad, Diazepam. Resumen: In a multicenter, double-blind trial, 310 patients who had received a diagnosis of generalized anxiety disorder were treated for 6 weeks with either abecarnil, diazepam, or placebo at mean daily doses of 12 mg of abecarnil or 22 mg of diazepam administered three times daily. Patients who were improved at 6 weeks could volunteer to continue double-blind treatment for a total of 24 weeks. Link: ./index.php?lvl=notice_display&id=31226